1. Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial. Issue 4 (April 2022) Authors: Kindler, Hedy L; Novello, Silvia; Bearz, Alessandra; Ceresoli, Giovanni L; Aerts, Joachim G J V; Spicer, James; Taylor, Paul; Nackaerts, Kristiaan; Greystoke, Alastair; Jennens, Ross; Calabrò, Luana; Burgers, Jacobus A; Santoro, Armando; Cedrés, Susana; Serwatowski, Piotr; Ponce, Santiago; Van Me... Journal: Lancet oncology Issue: Volume 23:Issue 4(2022) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reducing the multidimensionality of high-content screening into versatile powerful descriptors. (September 2010) Authors: Gorenstein, Julie; Zack, Ben; Marszalek, Joseph R.; Bagchi, Ansu; Subramaniam, Sai; Carroll, Pamela; Elbi, Cem Journal: Biotechniques Issue: Volume 49:Number 3(2010) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗